title: [Prognostic differences among different age limits in Chinese elderly patients with non-Hodgkin's lymphoma].
abstract: OBJECTIVE
  To explore the feasible age limits in Chinese elderly patients with non-Hodgkin's lymphoma (NHL).
  
  
  METHODS
  The clinical data of 507 patients with NHL who were admitted to Peking Union Medical College Hospital (PUMCH) from January 1990 to December 2007 were retrospectively analyzed. They were further followed up by reviewing medical records or by phone. The deadline of follow-up was October 2008.
  
  
  RESULTS
  The 5-year/8-year overall survival (OS) rates were 64.6%/45.7%, 53.0%/ 44.1%, 32.8%/17.5%, 40.0%/22.8%, and 19.8%/0, respectively, in patients aged < 60 years, 60-64 years, 65-69 years, 70-74 years, and > or = 75 years. The OS rate was significantly different between patients aged > or = 75 years and other age groups, and between patients aged 65-70 years and patients younger than 60 years (P < 0.05). Only age, serum albumin, and hemoglobin affected the survival status in elderly NHL patients.
  
  
  CONCLUSIONS
  Sixty-five years can be regarded as the age limit in Chinese NHL patients.
authors.affiliation: International Medical Service, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
authors.forename: Hai-Yan
authors.initials: HY
authors.lastname: Xie
authors.forename: Dao-Bin
authors.initials: DB
authors.lastname: Zhou
authors.forename: Shu-Jie
authors.initials: SJ
authors.lastname: Wang
authors.forename: Bing
authors.initials: B
authors.lastname: Han
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Li
authors.initials: L
authors.lastname: Jiao
authors.forename: Jian
authors.initials: J
authors.lastname: Li
authors.forename: Yong-Ji
authors.initials: YJ
authors.lastname: Wu
authors.forename: Yong-Qiang
authors.initials: YQ
authors.lastname: Zhao
authors.forename: Ti
authors.initials: T
authors.lastname: Shen
authors.forename: Tao
authors.initials: T
authors.lastname: Xu
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002681:China / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate